Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.

The molecular diagnosis of respiratory infection can be performed using different commercial multiplex-based PCR kits whose performances have been previously compared individually to those of conventional techniques. This study compared the practicability and the diagnostic performances of six CE-ma...

Full description

Bibliographic Details
Main Authors: Sylvie Pillet, Marina Lardeux, Julia Dina, Florence Grattard, Paul Verhoeven, Jérôme Le Goff, Astrid Vabret, Bruno Pozzetto
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058410/pdf/?tool=EBI
_version_ 1818459579680292864
author Sylvie Pillet
Marina Lardeux
Julia Dina
Florence Grattard
Paul Verhoeven
Jérôme Le Goff
Astrid Vabret
Bruno Pozzetto
author_facet Sylvie Pillet
Marina Lardeux
Julia Dina
Florence Grattard
Paul Verhoeven
Jérôme Le Goff
Astrid Vabret
Bruno Pozzetto
author_sort Sylvie Pillet
collection DOAJ
description The molecular diagnosis of respiratory infection can be performed using different commercial multiplex-based PCR kits whose performances have been previously compared individually to those of conventional techniques. This study compared the practicability and the diagnostic performances of six CE-marked kits available in 2011 on the French market, including 2 detecting viruses and atypical bacteria (from Pathofinder and Seegene companies) and 4 detecting only viruses (from Abbott, Genomica, Qiagen and Seegene companies). The respective sensitivity, specificity, accuracy and agreement of each multiplex technique were calculated by comparison to commercial duplex PCR tests (Argene/bioMérieux) used as gold standard. Eighty-eight respiratory specimens with no pathogen (n = 11), single infections (n = 33) or co-infections (n = 44) were selected to cover 9 viruses or groups of viruses and 3 atypical bacteria. All samples were extracted using the NUCLISENS® easyMAG™ instrument (bioMérieux). The overall sensitivity ranged from 56.25% to 91.67% for viruses and was below 50% with both tests for bacteria. The overall specificity was excellent (>94% for all pathogens). For each tested kit, the overall agreement with the reference test was strong for viruses (kappa test >0.60) and moderate for bacteria. After the extraction step, the hands-on time varied from 50 min to 2h30 and the complete results were available in 2h30 to 9 h. The spectrum of tested agents and the technology used to reveal the PCR products as well as the laboratory organization are determinant for the selection of a kit.
first_indexed 2024-12-14T23:16:36Z
format Article
id doaj.art-e427f3369df1486da1ab6528940cc499
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T23:16:36Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e427f3369df1486da1ab6528940cc4992022-12-21T22:44:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e7217410.1371/journal.pone.0072174Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.Sylvie PilletMarina LardeuxJulia DinaFlorence GrattardPaul VerhoevenJérôme Le GoffAstrid VabretBruno PozzettoThe molecular diagnosis of respiratory infection can be performed using different commercial multiplex-based PCR kits whose performances have been previously compared individually to those of conventional techniques. This study compared the practicability and the diagnostic performances of six CE-marked kits available in 2011 on the French market, including 2 detecting viruses and atypical bacteria (from Pathofinder and Seegene companies) and 4 detecting only viruses (from Abbott, Genomica, Qiagen and Seegene companies). The respective sensitivity, specificity, accuracy and agreement of each multiplex technique were calculated by comparison to commercial duplex PCR tests (Argene/bioMérieux) used as gold standard. Eighty-eight respiratory specimens with no pathogen (n = 11), single infections (n = 33) or co-infections (n = 44) were selected to cover 9 viruses or groups of viruses and 3 atypical bacteria. All samples were extracted using the NUCLISENS® easyMAG™ instrument (bioMérieux). The overall sensitivity ranged from 56.25% to 91.67% for viruses and was below 50% with both tests for bacteria. The overall specificity was excellent (>94% for all pathogens). For each tested kit, the overall agreement with the reference test was strong for viruses (kappa test >0.60) and moderate for bacteria. After the extraction step, the hands-on time varied from 50 min to 2h30 and the complete results were available in 2h30 to 9 h. The spectrum of tested agents and the technology used to reveal the PCR products as well as the laboratory organization are determinant for the selection of a kit.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058410/pdf/?tool=EBI
spellingShingle Sylvie Pillet
Marina Lardeux
Julia Dina
Florence Grattard
Paul Verhoeven
Jérôme Le Goff
Astrid Vabret
Bruno Pozzetto
Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.
PLoS ONE
title Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.
title_full Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.
title_fullStr Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.
title_full_unstemmed Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.
title_short Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.
title_sort comparative evaluation of six commercialized multiplex pcr kits for the diagnosis of respiratory infections
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058410/pdf/?tool=EBI
work_keys_str_mv AT sylviepillet comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT marinalardeux comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT juliadina comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT florencegrattard comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT paulverhoeven comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT jeromelegoff comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT astridvabret comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections
AT brunopozzetto comparativeevaluationofsixcommercializedmultiplexpcrkitsforthediagnosisofrespiratoryinfections